Villarreal Diana D, Lewis Katherine A, Cielo Mikhaela, Klausner Jeffrey D
From the Department of Pediatrics, Maternal Child and Adolescent/Adult Center for Infectious Disease and Virology, Los Angeles General Medical Center, University of Southern California.
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California.
Sex Transm Dis. 2025 Jul 1;52(7):395-401. doi: 10.1097/OLQ.0000000000002162. Epub 2025 Mar 14.
Congenital syphilis (CS) in the United States increased 10-fold in the last decade. At a large public hospital in Los Angeles, the numbers of infants born to mothers with untreated syphilis during pregnancy have continued to rise.
We compiled a retrospective case series from all infant rapid plasma reagin test results from 2022 to 2023 summarizing CS diagnosis and relevant diagnostic criteria. χ2 and Fisher exact tests were used to examine associations between maternal risk factors and CS diagnosis.
Maternal syphilis complicated 97 of 2367 live births (4.1%) at our institution. Approximately 36% (n = 35) of infants born to mothers with a history of syphilis (n = 94) were born to a mother with inadequately treated syphilis or concern for reinfection. Infants with exposure to maternal syphilis were mostly asymptomatic at birth but had a high frequency of abnormalities in laboratory and radiographic evaluation. Compared with infants with less likely or unlikely CS, mothers of infants with highly probable or possible CS were more likely to have methamphetamine use during pregnancy (41% vs. 69%, P = 0.02), cocaine use during pregnancy (2% vs. 14%, P = 0.03), opiate use during pregnancy (7% vs. 37%, P = <0.001), and no prenatal care (7% vs. 40%, P ≤ 0.001).
This case series identified maternal substance use and no prenatal care as risk factors for highly probable or possible CS, underscoring the vulnerability of this population and informing future work in prevention of this disease.
在过去十年中,美国先天性梅毒(CS)的发病率增长了10倍。在洛杉矶的一家大型公立医院,孕期梅毒未得到治疗的母亲所生婴儿的数量持续上升。
我们汇总了2022年至2023年所有婴儿快速血浆反应素试验结果的回顾性病例系列,总结了CS诊断及相关诊断标准。采用χ²检验和Fisher精确检验来研究母亲风险因素与CS诊断之间的关联。
在我们机构的2367例活产中,97例(4.1%)母亲患有梅毒。有梅毒病史的母亲(n = 94)所生的婴儿中,约36%(n = 35)的母亲梅毒治疗不充分或存在再次感染的担忧。暴露于母亲梅毒的婴儿出生时大多无症状,但在实验室和影像学评估中异常发生率很高。与CS可能性较小或不太可能患CS的婴儿相比,CS可能性很高或可能患CS的婴儿的母亲在孕期更有可能使用甲基苯丙胺(41%对69%,P = 0.02)、在孕期使用可卡因(2%对14%,P = 0.03)、在孕期使用阿片类药物(7%对37%,P < 0.001),且未接受产前检查(7%对40%,P ≤ 0.001)。
该病例系列确定母亲使用药物和未接受产前检查是CS可能性很高或可能患CS的风险因素,凸显了这一人群的脆弱性,并为今后预防该疾病的工作提供了参考。